Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities

The coronavirus disease 2019 (COVID-19) pandemic is caused by a newly emerged coronavirus (CoV) called Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2). COVID-19 patients with cardiovascular disease (CVD) comorbidities have significantly increased morbidity and mortality. The use of angi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, James Jiqi, Edin, Matthew L., Zeldin, Darryl C., Li, Chenze, Wang, Dao Wen, Chen, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346797/
https://www.ncbi.nlm.nih.gov/pubmed/32653530
http://dx.doi.org/10.1016/j.pharmthera.2020.107628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346797/
https://www.ncbi.nlm.nih.gov/pubmed/32653530
http://dx.doi.org/10.1016/j.pharmthera.2020.107628

Ejemplares similares